Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children
Phase 3
Completed
- Conditions
- Asthma
- First Posted Date
- 2004-10-11
- Last Posted Date
- 2021-11-23
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 440
- Registration Number
- NCT00094016
- Locations
- πΊπΈ
Allergy and Asthma Specialists, Huntington Beach, California, United States
πΊπΈPediatric Care Medical Group, Huntington Beach, California, United States
πΊπΈWest Coast Clinical Trials, Long Beach, California, United States
Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma
Phase 3
Completed
- Conditions
- Exercise-induced Bronchospasm
- Interventions
- First Posted Date
- 2004-06-17
- Last Posted Date
- 2021-11-24
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00085774
- Locations
- πΊπΈ
Colorado Allergy and Asthma Centers, PC, Lakewood, Colorado, United States
Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients
- First Posted Date
- 2003-10-29
- Last Posted Date
- 2021-11-24
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT00071552
- Locations
- πΊπΈ
National Jewish Medical and Research Center, Denver, Colorado, United States
Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
Phase 2
Completed
- Conditions
- Recurrent Glioblastoma Multiforme
- Interventions
- Drug: TP-38Drug: TP38
- First Posted Date
- 2003-10-29
- Last Posted Date
- 2012-01-20
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT00071539
Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
Phase 2
Terminated
- Conditions
- Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic OligodendrogliomaAnaplastic Mixed Oligoastrocytoma
- Interventions
- First Posted Date
- 2003-06-12
- Last Posted Date
- 2011-05-23
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00062504
Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique
- First Posted Date
- 2003-02-17
- Last Posted Date
- 2021-11-30
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT00054964
- Locations
- πΊπΈ
National Jewish Medical and Research Ceter, Denver, Colorado, United States
Effects of Talampanel on Patients With Advanced Parkinson's Disease
Phase 1
Completed
- Conditions
- DyskinesiasParkinson DiseaseMovement Disorders
- Interventions
- First Posted Date
- 2002-05-09
- Last Posted Date
- 2011-04-13
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT00036296
Multicenter Trial For Patients With Acute Crohn's Disease
Phase 2
Completed
- Conditions
- Crohn's Disease
- First Posted Date
- 2002-05-06
- Last Posted Date
- 2021-12-08
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Registration Number
- NCT00035503
- Locations
- πΊπΈ
Stuart Weisman, Palo Alto, California, United States
πΊπΈUniversity of Colorado Medical Center, Denver, Colorado, United States
πΊπΈWashington Hospital Center, Washington, District of Columbia, United States
Multicenter Trial for Adults With Partial Seizures
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2011-03-17
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 190
- Registration Number
- NCT00034814